This course is not available as an outside option. Health Technology Assessment a multidisciplinary process that summarises information about the medical, social, economic, and ethical issues related ...

Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care.

Incorporating systems thinking into drug value assessment promises more realistic evaluations of the impact of new therapies, ...

Please read the What we do section of the NICE website for technology appraisals. Guide to health technology evaluations. This describes the methods and processes that we follow when carrying out ...

MANILA, Philippines — The Philippine Alliance of Patient Organizations (PAPO) emphasized the vital role of health technology assessment (HTA) in advancing universal health care (UHC ...

It is a multidisciplinary activity which studies the clinical and the cost effectiveness of new pharmaceuticals or any other medical interventions, as well as how health policy might be impacted by ...

Health Technology Assessment (HTA) agencies usually rely on randomised controlled trials for clinical data when evaluating drugs, but these do not always tell the entire story.

The HTA Lab enables NICE to develop creative solutions to complex problems in health technology assessment. It offers a ‘safe space’ for creating solutions in collaboration with system partners and ...

Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, today announces an ...

The effort, named Health Technology Assessment (HTA 2025), was inaugurated today by India’s Minister of Health and Family Welfare, Jagat Prakash Nadda, via an international symposium.

The Indian Council of Medical Research (ICMR) has introduced the Medical Innovations Patent Mitra initiative to boost India's healthcare innovation and patent ecosystem. It offers comprehensive ...

In doing so, it provides inputs for analysing the impact of the current situation (baseline scenario) as well as potential future policy options (POs) for EU cooperation on Health Technology ...